Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Weusten BLAM, Bisschops R, Dinis-Ribeiro M, di Pietro M, Pech O, Spaander MCW, Baldaque-Silva F, Barret M, Coron E, Fernández-Esparrach G, Fitzgerald RC, Jansen M, Jovani M, Marques-de-Sa I, Rattan A, Tan WK, Verheij EPD, Zellenrath PA, Triantafyllou K, Pouw RE.
Endoscopy. 2023 Dec;55(12):1124-1146. doi: 10.1055/a-2176-2440. Epub 2023 Oct 9.
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma.
McLean LS, Cavanagh K, Hicks RJ, Callahan J, Xie J, Cardin A, Lim AM, Rischin D.
Cancer Imaging. 2021 Oct 13;21(1):57. doi: 10.1186/s40644-021-00426-2.
Arterial inflammation on [(18)F]FDG PET/CT in melanoma patients treated with and without immune checkpoint inhibitors: CHECK-FLAME I.
Polomski EAS, Kapiteijn EW, Heemelaar JC, van der Kolk AV, Kalisvaart TM, van de Burgt A, Dibbets-Schneider P, van Velden FHP, Seijkens TTP, Stöger JL, Jukema JW, de Geus-Oei LF, Antoni ML.
Atherosclerosis. 2024 Nov;398:118595. doi: 10.1016/j.atherosclerosis.2024.118595. Epub 2024 Sep 7.
PET/CT Specificities in (90)Y Imaging Post Radioembolization.
Stephan W, Michel H.
PET Clin. 2019 Oct;14(4):469-476. doi: 10.1016/j.cpet.2019.06.001. Epub 2019 Aug 6.
PET/CT for Target Delineation of Lung Cancer Before Radiation Therapy.
Manapov F, Eze C, Holzgreve A, Käsmann L, Nieto A, Taugner J, Unterrainer M.
Semin Nucl Med. 2022 Nov;52(6):673-680. doi: 10.1053/j.semnuclmed.2022.05.003. Epub 2022 Jun 30.
The Image Biomarker Standardization Initiative: Standardized Convolutional Filters for Reproducible Radiomics and Enhanced Clinical Insights.
Whybra P, Zwanenburg A, Andrearczyk V, Schaer R, Apte AP, Ayotte A, Baheti B, Bakas S, Bettinelli A, Boellaard R, Boldrini L, Buvat I, Cook GJR, Dietsche F, Dinapoli N, Gabryś HS, Goh V, Guckenberger M, Hatt M, Hosseinzadeh M, Iyer A, Lenkowicz J, Loutfi MAL, Löck S, Marturano F, Morin O, Nioche C, Orlhac F, Pati S, Rahmim A, Rezaeijo SM, Rookyard CG, Salmanpour MR, Schindele A, Shiri I, Spezi E, Tanadini-Lang S, Tixier F, Upadhaya T, Valentini V, van Griethuysen JJM, Yousefirizi F, Zaidi H, Müller H, Vallières M, Depeursinge A.
Radiology. 2024 Feb;310(2):e231319. doi: 10.1148/radiol.231319.
Lesion segmentation on (18)F-fluciclovine PET/CT images using deep learning.
Wang T, Lei Y, Schreibmann E, Roper J, Liu T, Schuster DM, Jani AB, Yang X.
Front Oncol. 2023 Dec 13;13:1274803. doi: 10.3389/fonc.2023.1274803. eCollection 2023.
Validation of CT doses of SPECT/CT and PET/CT hybrid devices: lessons learned.
Sera T, Porubszky T, Papos M, Elek R, Besenyi Z, Gion K, Bartha A, Pellet S, Pavics L.
Nucl Med Commun. 2014 May;35(5):534-8. doi: 10.1097/MNM.0000000000000087.
Measuring Total Metabolic Tumor Volume from (18)F-FDG PET: A Reality Check.
Boellaard R, Zwezerijnen GJC, Buvat I, Champion L, Hovhannisyan-Baghdasarian N, Orlhac F, Arens AIJ, Lobeek D, Celik F, Mitea C, Huijbregts JE, Tolboom N, de Keizer B, Valkema R, van Velden FHP, Dibbets-Schneider P, Wiegers SE, Lugtenburg PJ, Barrington SF, Zijlstra JM.
J Nucl Med. 2025 May 1;66(5):802-805. doi: 10.2967/jnumed.124.269271.
Comprehensive literature review of oral and intravenous contrast-enhanced PET/CT: a step forward?
Metrard G, Cohen C, Bailly M.
Front Med (Lausanne). 2024 Mar 19;11:1373260. doi: 10.3389/fmed.2024.1373260. eCollection 2024.
